1. Home
  2. ALLO vs FDBC Comparison

ALLO vs FDBC Comparison

Compare ALLO & FDBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allogene Therapeutics Inc.

ALLO

Allogene Therapeutics Inc.

HOLD

Current Price

$1.48

Market Cap

252.9M

Sector

Health Care

ML Signal

HOLD

Logo Fidelity D & D Bancorp Inc.

FDBC

Fidelity D & D Bancorp Inc.

HOLD

Current Price

$43.75

Market Cap

253.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALLO
FDBC
Founded
2017
1902
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
252.9M
253.8M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
ALLO
FDBC
Price
$1.48
$43.75
Analyst Decision
Strong Buy
Analyst Count
12
0
Target Price
$8.27
N/A
AVG Volume (30 Days)
4.6M
7.1K
Earning Date
03-12-2026
01-27-2026
Dividend Yield
N/A
3.90%
EPS Growth
N/A
68.46
EPS
N/A
4.51
Revenue
N/A
$88,597,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$9.78
Revenue Growth
N/A
24.36
52 Week Low
$0.86
$37.00
52 Week High
$3.78
$50.00

Technical Indicators

Market Signals
Indicator
ALLO
FDBC
Relative Strength Index (RSI) 47.09 47.49
Support Level $1.54 $43.01
Resistance Level $1.83 $45.97
Average True Range (ATR) 0.13 1.17
MACD -0.00 0.15
Stochastic Oscillator 25.23 55.33

Price Performance

Historical Comparison
ALLO
FDBC

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

About FDBC Fidelity D & D Bancorp Inc.

Fidelity D & D Bancorp Inc is a bank holding company. Through its wholly-owned state-chartered commercial bank subsidiary, The Fidelity Deposit and Discount Bank (the Bank), it offers a full range of traditional banking services. The Bank has a personal and corporate trust department and also provides alternative financial and insurance products with asset management services. Its primary market areas are Lackawanna, Luzerne and Northampton Counties, Pennsylvania. The company's primary deposit products are demand deposits and interest-bearing time, money market and savings accounts. It offers a full array of loan products to meet the needs of retail and commercial customers. Company includes segments: Commercial and Industrial, Commercial Real Estate, Consumer, Residential Real Estate.

Share on Social Networks: